Table 2.
Cardiac manifestation | CMR utility | Sequences |
---|---|---|
What has CMR to offer in systemic lupus erythematosus? | ||
Valvular Heart Disease | Assessment of hemodynamic significance. Reproducible follow-up. | Cine—SSFP, cine-FGE, PhC, 4D-flow |
Pericarditis/Pericardial Effusion | Identification Assessment of severity and hemodynamic significance, Detection of inflammation. Detection of constriction. | Cine—SSFP Free-breathing real-time cine T1-W, T2-W STIR LGE-PSIR |
RV dysfunction | The gold standard for RV function | Cine—SSFP Strain |
LV dysfunction | The gold standard for LV function | Cine—SSFP Strain, diffusion tensor |
Myocarditis | Identification and quantification. Follow up free of radiation. |
T2-W T1, T2-mapping, ECV LGE-PSIR |
Vascular involvement | Coronary arteries—atherosclerosis, thrombosis, and vasospasm. | Cine SSFP, Stress FPP LGE-PSIR, MR coronary angiography |
Great vessels—Aortic involvement | Cine—SSFP, cine-FGE 4D-flow, MRA |
|
Microvascular dysfunction | Stress FPP LGE-PSIR |
SSFP, steady-state free precession; FGE, fast gradient echo; PhC, phase contrast; T2-W, T2-weighted; STIR, short tau inversion recovery; LGE, late gadolinium enhancement; PSIR, Phase-sensitive inversion recovery; MRA, magnetic resonance angiography; ECV, extracellular volume; FPP, first-pass perfusion; MR, magnetic resonance.